4-Methylmorpholine → HCID 90039588、化合物
反応式
[F:1][C:2]([F:17])([F:16])[CH:3]([C:5]1[CH2:6][C:7](F)([C:11]([F:14])([F:13])[F:12])[CH:8]=[CH:9][CH:10]=1)[NH2:4].[CH3:18][O:19][C:20]([C:22]1[CH:23]=[C:24]2[CH:31]=[C:30]([C:32](O)=[O:33])[NH:29][C:25]2=[N:26][C:27]=1[CH3:28])=[O:21].F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.CN1CCOCC1>CN(C)C=O.O>[CH3:28][C:27]1[N:26]=[C:25]2[NH:29][C:30]([C:32](=[O:33])[NH:4][CH:3]([C:5]3[CH:10]=[CH:9][CH:8]=[C:7]([C:11]([F:14])([F:13])[F:12])[CH:6]=3)[C:2]([F:17])([F:16])[F:1])=[CH:31][C:24]2=[CH:23][C:22]=1[C:20]([O:19][CH3:18])=[O:21]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
2,2,2-Trifluoro-1-[3-fluoro-3-(trifluoromethyl)phenyl]ethanamine (2.07 g, 8.54 mmol) was dissolved in N,N-dimethylformamide (6 ml), and 5-(methoxycarbonyl)-6-methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid (1.60 g, 6.83 mmol), N-[(1H-benzotriazol-1-yloxy)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate (2.56 g, 6.83 mmol) and 4-methylmorpholine (2.53 ml, 20.50 mmol) were added. The reaction mixture was stirred at room temperature for 16 h and then water was added. The aqueous phase was extracted three times with ethyl acetate and the extract was dried over sodium sulphate, adsorbed on silica gel and chromatographed with ethyl acetate. This gave 1.74 g (55% of theory) of methyl 6-methyl-2-({2,2,2-trifluoro-1-[3-(trifluoromethyl)phenyl]ethyl}carbamoyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate. HPLC-MS: log P=3.37; mass (m/z): 460.1 (M+H)+; 1H-NMR (D6-DMSO): δ 2.79 (s, 3H), 3.87 (s, 2H), 6.29-6.32 (m, 1H), 7.50 (s, 1H), 7.70-7.74 (m, 1H), 7.82-7.84 (m, 1H), 8.05 (d, 1H), 8.18 (s, 1H), 8.66 (m, 1H), 9.72-9.74 (m, 1H).
後処理
- extractionThe aqueous phase was extracted three times with ethyl acetate
- dry with materialthe extract was dried over sodium sulphate
- customchromatographed with ethyl acetate
出典と根拠
- ORDレコード
- ord-4d0df455f9354ec1a2c7a725b3627ca4
- 出典データセット
- uspto-grants-2016_05
- 特許番号
- US09345247B2
反応ノート
読み込み中…